Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design*

Bibliography

• Dye C, Watt CJ, Bleed DM, et al. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 2005;293:2767-75
   PubMed Web of Science ®Google Scholar
• Global tuberculosis report 2012. World Health Organization, 2012
   Google Scholar
• Sung JC, Padilla DJ, Garcia-Contreras L, et al. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res 2009;26:1847-55
   PubMed Web of Science ®Google Scholar
• Toit LCD, Pillay V, Danckwerts MP, et al. Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system. J Pharm Sci 2008;97:2176-207
   PubMed Web of Science ®Google Scholar
• Vinagradov SV, Bronich TK, Kabanov AV. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 2002;54:223-33
   PubMedGoogle Scholar
• Panyama J, Vabhasetwa V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329-47
   PubMed Web of Science ®Google Scholar
• Soppimatha KS, Aminabhavia TM, Kulkarnia AR. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1-20
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24
   PubMed Web of Science ®Google Scholar
• Lin SY, Chen KS, Teng HH, et al. In vitro degradation and dissolution behaviours of microspheres prepared by three low molecular weight polyesters. J Microencapsul 2000;17:577-86
   PubMed Web of Science ®Google Scholar
• Wolf AJ, Linas B, Trevejo-Nunez GJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007;179:2509-19
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to Practice. Pharmacol Rev 2001;53:283-318
   PubMed Web of Science ®Google Scholar
• Thomas C. A literature review of the problems of delayed presentation for treatment and non-completion of treatment for tuberculosis in less developed countries and ways of addressing these problems using particular implementations of the DOTS strategy. J Manag Med 2002;16:371-400
   PubMedGoogle Scholar
• Azhar GS. DOTS for TB relapse in India: a systematic review. Lung India 2012;29:147-53
   PubMedGoogle Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticles drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487-90
   PubMed Web of Science ®Google Scholar
• Faustini A, Hall AJ, Perucci CA. Risk factors for Multi drug resistant tuberculosis in Europe: a systematic review. Thorax 2006;61:158-63
   PubMed Web of Science ®Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27-105
   PubMed Web of Science ®Google Scholar
• Leardi R. Experimental design in chemistry: a tutorial. Anal Chim Acta 2009;652:161-72
   PubMed Web of Science ®Google Scholar
• Hibbert DB. Experimental design in chromatography: a tutorial review. J Chromatogr B 2012;910:2-13
   PubMed Web of Science ®Google Scholar
• Zambauxa MF, Bonneauxa F, Grefb R, et al. Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 1998;50:31-40
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Vuddanda PR, et al. Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles. Colloid Surf B 2010;81:563-9
   PubMed Web of Science ®Google Scholar
• Goyal P, Pandey S, Udupa N. Simultaneous Spectrophotometric estimation of Isoniazid and Rifampicin from combined dosage form. Indian J Pharm Sci 2002;64:76-8
   Google Scholar
• Rawat MK, Jain A, Mishra A, et al. Effect of lipid matrix on characteristics of repaglinide loaded solid lipid nanoparticles for oral delivery. Ther Deliv 2010;1:63-73
   PubMedGoogle Scholar
• Mira EG, Egea MA, Souto EB, et al. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 2011;22:045101
   Google Scholar
• Reddy LH, Murthy RS. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS Pharm Sci Technol 2005;6:158-66
   PubMed Web of Science ®Google Scholar
• Garcia X, Escribano E, Domenech J, et al. In vitro characterization and in vivo analgesic and anti-allodynic activity of PLGA-bupivacaine nanoparticles. J Nanopart Res 2011;13:2213-23
   Web of Science ®Google Scholar
• Tiwari S, Chaturved AP, Tripathi YB, et al. Macrophage-specific targeting of isoniazid through mannosylated gelatin microspheres. APS Pharm Sci Tech 2011;12:900-8
   PubMed Web of Science ®Google Scholar
• Panyam J, Dali MM, Sahoo SK, et al. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. J Control Release 2003;92:173-87
   PubMed Web of Science ®Google Scholar
• Kumar RMN. Nano and microparticles as controlled drug delivery devices. J Pharm Sci 2000;3:234-58
   Web of Science ®Google Scholar
• Cronholm P, Midander K, Karlsson HL, et al. Effect of sonication and serum proteins on copper release from copper nanoparticles and the toxicity towards lung epithelial cells. Nanotoxicology 2011;5:269-81
   PubMed Web of Science ®Google Scholar
• Geng H, Song H, Qi J, et al. Sustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix. Nanoscale Res Lett 2011;6:312
   PubMed Web of Science ®Google Scholar
• Feczko T, Toth J, Dosa G, et al. Influence of process conditions on the mean size of PLGA nanoparticles. Chem Eng Process 2011;50:846-53
   Web of Science ®Google Scholar
• Hamishehkara H, Emamib J, Najafabadic AR, et al. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloid Surf B 2009;74:340-9
   PubMed Web of Science ®Google Scholar
• Hsu YY, Hao T, Hedley ML. Comparison of process parameters for microencapsulation of plasmid DNA in poly (d,l-lactic-co-glycolic) acid microspheres. J Drug Target 1999;7:313-23
   PubMed Web of Science ®Google Scholar
• Tenga X, Yang H. Effects of surfactants and synthetic conditions on the sizes and self-assembly of monodisperse iron oxide nanoparticles. J Mater Chem 2004;14:774-9
   Web of Science ®Google Scholar
• Kanchan V, Panda AK. Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response. Biomaterials 2007;28:5344-57
   PubMed Web of Science ®Google Scholar
• Rafati H, Coombes AGA, Adler J, et al. Protein-loaded PLGA microparticles for oral administration: formulation, structural and release characteristics. J Control Release 1997;43:89-102
   Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. Solvent selection in the preparation of PLA macrospheres prepared by solvent evaporation method. Int J Pharm 1988;43:179-86
   Web of Science ®Google Scholar
• Agrawal SD, Ashokraj Y, Bharatam PV, et al. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci 2004;22:127-44
   PubMed Web of Science ®Google Scholar
• Angadi SC, Manjeshwar LS, Aminabhavi TM. Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of Isoniazid. Int J Biol Macromol 2010;47:171-9
   PubMed Web of Science ®Google Scholar
• Xin F, Jian C, Jianming R, et al. Preparation and properties of poly(lactide-co-glycolide)/bone meals composite materials. Polym Plast Technol Eng 2010;49:309-15
   Web of Science ®Google Scholar
• Freire FD, Aragao CFS, Moura TFA, et al. Thermal studies of isoniazid and mixtures with Rifampicin. J Therm Anal Calorim 2009;97:333-6
   Web of Science ®Google Scholar
• Hest RV, Baars H, Kik S, et al. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment. Clin Infect Dis 2004;39:488-96
   PubMed Web of Science ®Google Scholar
• Clemens DL, Lee BY, Xue M, et al. Targeted intracellular delivery of antituberculosis drugs to mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob Agents Chemother 2012;56:2535-45
   PubMed Web of Science ®Google Scholar